APASL STC Lectures 2
| Title | Authors | |
|---|---|---|
| A Rational Evidence-based Approach to Abnormal Liver Tests | Jane D. Ricaforte-Campos, MD FPCP, FPSG, FPSDE | Download |
| AASLD Guidelines and HCC: US based commentary | Robert G Gish MD | Download |
| ACUTE ON CHRONIC LIVER FAILURE | Juliet L. Gopez-Cervantes MD | Download |
| Advances in HCV Treatment: Beyond Triple Therapy | Jacob George | Download |
| Alcohol, Environment and HCC | Byung Chul Yoo MD PhD | Download |
| Alcoholic Liver Disease: What are the treatment options? | Joseph C. Bocobo MD | Download |
| APASL and CEVHAP Partnership: a Hepatitis-Free World | Dr Locarnini Dr Wallace | Download |
| APASL and CEVHAP Partnership: Its Vision for Hepatitis-free World | Darrell HG Crawford MD FRACP | Download |
| APASL and CEVHAP Partnership: Its Vision for Hepatitis-free World | Dr John Wallac | Download |
| APASL Guideline on HCC | Masatoshi Kudo MD PhD | Download |
| ASCITES AND HYPONATREMIA IN LIVER CIRRHOSIS: HOW AND WHEN TO INTERVENE | Judy Lao-Tan, MD FPCP FPSG FPSDE | Download |
| Assessment of Resectability of HCC | Ma. Vanessa H de Villa MD PhD | Download |
| CE-Ultrasound US Elastography for HCC | Byung Ihn Choi M. | Download |
| Challenges in diagnosis of hepatocellular carcinoma | Do Young Kim | Download |
| CLINICAL PRACTICE GUIDELINES: PARADIGMS IN MANAGEMENT OF HCC EASL-EORTC Guidelines | Bruno Sangro | Download |
| Clinical Staging for Hepatocellular Carcinoma: Eastern Perspectives | Osamu Yokosuka MD | Download |
| Clinical Staging of HCC: A Western Perspective | W Ray Kim MD | Download |
| Combination of Transarterial Locoregional Therapy with Systemic Therapy | Janus Ong MD MPH | Download |
| Comparison of efficacy between hepatic arterial infusion chemotherapy and sorafenib | Si Hyun Bae | Download |
| Current Challenges in Systemic Therapy for Hepatocellular Carcinoma | Ann-Lii Cheng MD PhD | Download |
| Estimation of Prognosis and Candidacy for Liver Transplantation | Allan M Concejero MD | Download |
| Evaluation and Management of the Surgical Patient with Cirrhosis: Understanding and Justifying the Risk | Dr Eternity D Labio FPCP FPSG FPSDE | Download |
| Evolving Concepts and Strategies in Liver Transplantation for Hepatocellular Carcinoma | Chung Mau Lo | Download |
| Evolving Experience with SIRT in the Philippines | Ma. Vanessa H de Villa MD PhD | Download |
| Genomics in HCC Implications for Diagnosis and Treatment | Lewis R Roberts MB ChB PhD | Download |
| HBsAg Quantification: Should It be Part of The Treatment Algorithm for CHB? | Stephen N. Wong, MD | Download |
| HBV related HCC: The role of antiviral therapy in its prevention and management – ETV real world experience | Dr Grace Lai-Hung Wong MBChB (Hons, CUHK), MD (CUHK), FRCP(Edin), FHKCP, FHKAM | Download |
| HCC in 3D Dimension Direction Decision | Masao Omata | Download |
| HEPATIC ENCEPHALOPATHY Are we doing any better? | Evelyn B. Dy, M.D. | Download |
| Hepatocellular Carcinoma Screening and Surveillance Strategies | Diana Alcantara-Payawal, M.D. FPCP, FPSG, FPSDE | Download |
| HIV coinfection and HCC | George KK Lau, MD | Download |
| How do you optimize HCV Treatment for Cirrhotic Patients | Seng Gee Lim | Download |
| ICG Fluorescence Imaging | Takeaki ISHIZAWA and Norihiro KOKUDO | Download |
| Immunizations and Medication Use in Cirrhosis: Which, How and When | Fernando V. Ona, MD, FACG | Download |
| Immunotherapy for HCC | Jack R. Wands, MD | Download |
| Infectious complications in patients with cirrhosis: What shall we do? | Jenny Lim Limquiaco, MD | Download |
| Innovations in HCC Imaging: MDCT/MRI | Anthony E. Cheng, M.D. | Download |
| Is there a role for Peg-Interferon add-on or switch therapy in patients on long term Nucleoside therapy? | Prof. Teerha Piratvisuth | Download |
| Long-term Efficacy and Safety of Nucleos/tide Analogues | Professor CL Lai | Download |
| Management of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy? | Teerha Piratvisuth | Download |
| Management of Chronic Hepatitis B: Why we care and how to treat? | Prof. Khin Maung Win | Download |
| Management of HCV in patients co-infected with HIV | Robert Gish MD | Download |
| Management of Intermediate Stage HCC | Masatoshi Kudo, MD, PhD | Download |
| Management of Treatment-Nai?ve G1 Patients with F1 Fibrosis: Treat Now or Wait? | W. Ray Kim, MD | Download |
| Metabolic Syndrome and HCC | Jacob George | Download |
| Molecular Classification of HCC | Michiie Sakamoto MD, PhD | Download |
| NAFLD: Does Anything Help at all? | Prof. ALAAELDIN IBRAHIM (MD) | Download |
| Novel prognostic biomarkers for hepatocellular carcinoma | Do Young Kim | Download |
| Nutrition in Cirrhosis | Angela D. Salvaña, MD | Download |
| Ongoing Clinical Trials in Hepatocellular Carcinoma | Pierce K.H Chow MD PhD | Download |
| Optimal Therapy for Genotype non-1 in Asia Pacific? | Dr Saeed Hamid | Download |
| Pathological Classification of Hepatocellular Carcinoma | Glenda Lyn Y. Pua, M.D. | Download |
| Percutaneous Urtrasound-Guided Radiofrequency Ablation for Extrahepatic Neoplasms | S Sato, T Kawai, S Obi | Download |
| Playing the Long Game: Can We Reach the Ultimate Goal of CHB Therapy? | Jose D Sollano | Download |
| Real-world Outcomes with Long-term CHB Management | Diana A. Payawal, MD | Download |
| Role of Antivirals in HBV-related HCC | CL Lai | Download |
| Role of Antivirals in HBV-related HCC | Professor Darrell HG Crawford MD FRACP | Download |
| Role of Antivirals in the Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis | Laurentius A. Lesmana | Download |
| Role of Biopsy in the Era of Targeted Therapy | Ryosuke Tateishi, MD, PhD | Download |
| Role of PET/CT in Hepatocellular Carcinoma | Dr. Thomas K.C.Cheng | Download |
| Selective Internal Radiation Therapy | Jefferson R. Pagsisihan, MD, DPSNM | Download |
| SETTING THE STAGE : Understanding the pathogenesis of hepatic fibrosis and portal hypertension | Jade D. Jamias, MD, FPCP, FPSG,FPSDE | Download |
| Should all genotype 1 patients be started on triple therapy in Asia-Pacific? | George KK Lau | Download |
| Should Elderly CHC Patients (>70 years old) be Treated? | Deepak Amarapurkar | Download |
| SIRT for Intermediate and Advanced HCC | Bruno Sangro | Download |
| SIRT for liver cancer | Dr. Stephen L. Chan | Download |
| Stem Cell Therapy for HCC | Lewis R. Roberts, MB ChB, PhD | Download |
| SURVIVAL ANALYSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA : IMPLICATIONS OF PATIENT CHARACTERISTICS AND MODE OF TREATMENT | Arl Ann S. Mendoza-Manzo, PM Villareal, RE Carpio, MM Chan, CD Dalupang, AE Ismael, JD Sollano, SN Wong | Download |
| Targeted Radiation Therapy for HCC | Hee Chul Park | Download |
| The Epidemiology of Hepatocellular Carcinoma in the Asia Pacific | Jose D Sollano, MD | Download |
| The Management of Advanced Stage Hepatocellular Carcinoma | Pierce K.H Chow MD PhD | Download |
| Therapeutic Response Assessment and Endpoints in HCC | Ronnie T.P. Poon, MBBS, MS, PhD | Download |
| Variceal Bleeding: To Band, Block, or TIPS? | ALBERT E. ISMAEL, MD | Download |
| Viral Hepatocarcinogensis and Signaling Pathways | Jack R. Wands, MD | Download |
| What’s on the Horizon for Treatment for CHB? New Targets for HBV? | Professor Stephen Locarnini | Download |
| When patients fail on molecular targeted therapy: what to do in 2013 | Dr. Stephen L. Chan | Download |
| Where East Meets West Search for a cure | Robert G Gish MD | Download |
